The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis

Imran Sheikh, Eric Fontenot, Nisheet Waghray, Mohammad Ismail, Claudio Tombazzi, J. Lacey Smith

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Post-ERCP pancreatitis (PEP) is the most common major complication associated with ERCP. Beginning with an overview of the risk factors for the development of PEP, this review introduces the mechanism of injury in PEP and the role of pharmacological prevention. NSAIDs are increasingly found to offer prevention against the development of PEP, and their mechanism and supportive data are summarized, especially in relationship to the practice of prophylactic pancreatic duct stenting.

Original languageEnglish (US)
Pages (from-to)219-224
Number of pages6
JournalJournal of the Pancreas
Volume15
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Endoscopic Retrograde Cholangiopancreatography
Pancreatitis
Anti-Inflammatory Agents
Pharmaceutical Preparations
Pancreatic Ducts
Non-Steroidal Anti-Inflammatory Agents
Pharmacology
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. / Sheikh, Imran; Fontenot, Eric; Waghray, Nisheet; Ismail, Mohammad; Tombazzi, Claudio; Lacey Smith, J.

In: Journal of the Pancreas, Vol. 15, No. 3, 01.01.2014, p. 219-224.

Research output: Contribution to journalReview article

@article{593e2424da6d427fbf49bd33f62bc72e,
title = "The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis",
abstract = "Post-ERCP pancreatitis (PEP) is the most common major complication associated with ERCP. Beginning with an overview of the risk factors for the development of PEP, this review introduces the mechanism of injury in PEP and the role of pharmacological prevention. NSAIDs are increasingly found to offer prevention against the development of PEP, and their mechanism and supportive data are summarized, especially in relationship to the practice of prophylactic pancreatic duct stenting.",
author = "Imran Sheikh and Eric Fontenot and Nisheet Waghray and Mohammad Ismail and Claudio Tombazzi and {Lacey Smith}, J.",
year = "2014",
month = "1",
day = "1",
doi = "10.6092/1590-8577{\%}2F2258",
language = "English (US)",
volume = "15",
pages = "219--224",
journal = "Journal of the Pancreas",
issn = "1590-8577",
publisher = "E.S. Burioni Ricerche Bibliografiche",
number = "3",

}

TY - JOUR

T1 - The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis

AU - Sheikh, Imran

AU - Fontenot, Eric

AU - Waghray, Nisheet

AU - Ismail, Mohammad

AU - Tombazzi, Claudio

AU - Lacey Smith, J.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Post-ERCP pancreatitis (PEP) is the most common major complication associated with ERCP. Beginning with an overview of the risk factors for the development of PEP, this review introduces the mechanism of injury in PEP and the role of pharmacological prevention. NSAIDs are increasingly found to offer prevention against the development of PEP, and their mechanism and supportive data are summarized, especially in relationship to the practice of prophylactic pancreatic duct stenting.

AB - Post-ERCP pancreatitis (PEP) is the most common major complication associated with ERCP. Beginning with an overview of the risk factors for the development of PEP, this review introduces the mechanism of injury in PEP and the role of pharmacological prevention. NSAIDs are increasingly found to offer prevention against the development of PEP, and their mechanism and supportive data are summarized, especially in relationship to the practice of prophylactic pancreatic duct stenting.

UR - http://www.scopus.com/inward/record.url?scp=84901620589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901620589&partnerID=8YFLogxK

U2 - 10.6092/1590-8577%2F2258

DO - 10.6092/1590-8577%2F2258

M3 - Review article

C2 - 24865531

AN - SCOPUS:84901620589

VL - 15

SP - 219

EP - 224

JO - Journal of the Pancreas

JF - Journal of the Pancreas

SN - 1590-8577

IS - 3

ER -